Combining Lifestyle Modification and Liraglutide to Improve Weight Loss and Health Outcomes

Trial Profile

Combining Lifestyle Modification and Liraglutide to Improve Weight Loss and Health Outcomes

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 29 Nov 2017

At a glance

  • Drugs Liraglutide (Primary)
  • Indications Obesity
  • Focus Therapeutic Use
  • Acronyms MODEL
  • Most Recent Events

    • 22 Nov 2017 Planned End Date changed from 1 May 2018 to 1 Aug 2018.
    • 22 Nov 2017 Planned primary completion date changed from 1 May 2018 to 1 Aug 2018.
    • 10 Jun 2017 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top